...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of Molecular Tools for Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Stool Specimens from Patients with Pulmonary Tuberculosis
【24h】

Evaluation of Molecular Tools for Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Stool Specimens from Patients with Pulmonary Tuberculosis

机译:肺结核患者粪便标本中结核分枝杆菌检测和药敏试验的分子工具评价

获取原文
           

摘要

Pulmonary tuberculosis diagnosis is difficult when patients cannot produce sputum. Most sputum is swallowed, and tuberculosis DNA can survive intestinal transit. We therefore evaluated molecular testing of stool specimens for detecting tuberculosis originating from the lungs. Paired stool and sputum samples (n = 159) were collected from 89 patients with pulmonary tuberculosis. Control stool samples (n = 47) were collected from patients without tuberculosis symptoms. Two techniques for DNA extraction from stool samples were compared, and the diagnostic accuracy of the PCR in stool was compared with the accuracy of sputum testing by PCR, microscopy, and culture. A heminested IS6110-PCR was used for tuberculosis detection, and IS6110-PCR-positive stool samples then underwent rifampin sensitivity testing by universal heteroduplex generator PCR (heteroduplex-PCR) assay. For newly diagnosed pulmonary tuberculosis patients, stool IS6110-PCR had 86% sensitivity and 100% specificity compared with results obtained by sputum culture, and stool PCR had similar sensitivities for HIV-positive and HIV-negative patients (P = 0.3). DNA extraction with commercially available spin columns yielded greater stool PCR sensitivity than DNA extraction with the in-house Chelex technique (P = 0.007). Stool heteroduplex-PCR had 98% agreement with the sputum culture determinations of rifampin resistance and multidrug resistance. Tuberculosis detection and drug susceptibility testing by stool PCR took 1 to 2 days compared with an average of 9 weeks to obain those results by traditional culture-based testing. Stool PCR was more sensitive than sputum microscopy and remained positive for most patients for more than 1 week of treatment. In conclusion, stool PCR is a sensitive, specific, and rapid technique for the diagnosis and drug susceptibility testing of pulmonary tuberculosis and should be considered when sputum samples are unavailable.
机译:当患者无法产生痰液时,很难诊断肺结核。多数痰被吞咽,肺结核DNA可以在肠道运输中存活。因此,我们评估了粪便标本的分子测试,以检测源自肺的结核病。从89例肺结核患者中收集了成对的粪便和痰标本( n = 159)。从无结核病症状的患者中收集对照大便样本( n = 47)。比较了从粪便样品中提取DNA的两种技术,并将粪便中PCR的诊断准确性与通过PCR,显微镜和培养进行痰液检测的准确性进行了比较。使用半消臭的IS 6110 -PCR检测结核病,然后通过通用异源双链发生器PCR(heteroduplex-PCR)对IS 6110 -PCR阳性粪便样本进行利福平敏感性测试。分析。对于新诊断的肺结核患者,粪便IS 6110 -PCR与痰培养结果相比灵敏度为86%,特异性为100%,粪便PCR对HIV阳性和HIV阴性患者的敏感性相似。 ( P = 0.3)。与使用内部Chelex技术进行DNA提取相比,使用市售旋转柱进行DNA提取产生的粪便PCR灵敏度更高( P = 0.007)。粪便异源双链PCR与痰培养测定的利福平耐药性和多药耐药性具有98%的一致性。粪便PCR检测结核病和药物敏感性测试需要1-2天,而传统的基于培养的检测结果平均要花费9周。粪便PCR比痰液显微镜检查更为敏感,并且对于大多数患者而言,治疗超过1周仍呈阳性。总之,粪便PCR是诊断,诊断和药敏试验肺结核的灵敏,特异和快速的技术,在无法获得痰液样本时应考虑使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号